David A. Cory - President and CEO, Director at Eiger BioPharmaceuticals, Inc.

Issuer-level insider activity

Role
President and CEO, Director
Issuer ticker
EIGR
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by David A. Cory since 20 Aug 2025

Reported holdings for David A. Cory in Eiger BioPharmaceuticals, Inc.

Form 4 holding President and CEO, Director

Eiger BioPharmaceuticals, Inc.

Security class
Common Stock
Shares / value
169,183
Estimated value
$50,366
Report date
11 Mar 2022
Price
$0.2977
Ownership
Direct
Form 4 holding President and CEO, Director

Eiger BioPharmaceuticals, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
281,000
Estimated value
Report date
11 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for David A. Cory in Eiger BioPharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .